Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced, Persistent, or Recurrent Endometrial Cancer × Letrozole × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 57 Endometrial Neoplasms 6 Ovarian Neoplasms 4 Advanced Breast Cancer 4 Polycystic Ovary Syndrome 3 Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Neoplasms, Male 3 HR+/HER2- Breast Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Cancer 1 Locoregional Recurrence 1 Leiomyoma 1 Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Stromal Tumors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡